BIOTECH firm Epistem has signed a Tuberculosis diagnostic supply and distribution agreement with medical technology group Becton, Dickinson and Company. The Manchester company's Genedrive machine uses molecular diagnosis to provide a rapid test which can highlight a range of conditions within 30 minutes. The agreement, on a global basis excluding India and the Indian Sub Continent, includes an upfront payment of $1m with further milestone payments of up to $3m, alongside escalating supply volumes over the next five years. T......for the full story register now for free or login below...